📰 Biotech Ceo News
Biotech Ceo News Today
Fast, Ad-Free News Updates
Stay updated with breaking news from Biotech Ceo. Real-time updates on events, politics, business and more.
January 27, 2023
BioTech company founder and CEO Bryan Johnson has been spending millions to reduce his age via sophisticated technology. His biotech company is running a project named ‘BluePrint’ that aims to alter the epigenetic constitution of humans, for which Johnson is also a part of the trials.
May 10, 2022
Seagen’s co-founder Clay Siegall, Ph.D., has been put on a leave of absence after an alleged incident of domestic violence that happened at his home.
March 11, 2022
After its first commercial launch in Carvykti, Legend Biotech's CEO talked up the rising CAR-T star's cell therapy ambitions.
March 10, 2022
Moderna’s business took flight in 2021 thanks to authorizations for its COVID-19 vaccine, and so did its CEO’s pay.
March 8, 2022
Nearly five years after unveiling the first clinical data for its BCMA-targeted CAR-T therapy, Legend Biotech has transitioned into a commercial company with an FDA approval for Carvykti and Johnso
March 4, 2022
Hutchmed’s very first employee and longtime CEO, Chrisian Hogg, is retiring after a 15-year run, just as the Chinese company is prepping to break into the U.S. market.
February 26, 2022
Adagio Therapeutics, attempting to bring COVID-19 treatments to market after raising a massive haul of capital during the pandemic, will have to go soul searching as its CEO is out the door with no
February 4, 2022
Pfizer picks from Roche's executive team, snagging pharma early R&D leader William Pao as the Big Pharma's next chief development officer. Leo Pharma poaches from ... a Danish meme stock for its new CEO, who will lead a reorganization of the dermatology biopharma. And Sio Gene Therapies CEO Cheruvu is out the door as Parkinson's program also hits the exit.
January 27, 2022
Nine-year Johnson & Johnson Chief Scientific Officer Paul Stoffels is jumping back into biotech as the CEO of Galapagos, which he helped lay the foundation for in the late 1990s. He will lead the European biopharma as it looks to rebound from multiple setbacks in 2021.
December 10, 2021
Former FDA head Stephen Hahn is adding a new title to his role at Flagship Pioneering: CEO of the incubator's blood cancer test startup Harbinger Health. Takeda's oncology leader Rachael Brake heads to Corbus as chief scientific officer charged with redefining scope of early-stage pipeline. Goldfinch Bio snags 13-year Ardelyx vet as CSO.